Welcome to PsychU!

The Next Crisis: Major Depressive Disorder – Pharmacist’s Corner Section Advisor Interview On PsychU’s Theme For October

Depression is one of the most common psychiatric illnesses affecting approximately 8% of American adults in a given year. Despite …

You must be logged-in to view this content.

Neuroimaging Updates In Schizophrenia & The Future Of Precision Medicine: An Interview With Dr. Anissa Abi-Dargham

Dr. Anissa Abi-Dargham will provide updates on the use of neuroimaging in Schizophrenia. She will focus on the recent findings …

You must be logged-in to view this content.

Log In

Oklahoma Law Limits Use Of Antipsychotic Drugs In Assisted Living Communities

On April 19, 2021, Oklahoma Governor Kevin Stitt signed legislation to limit the use of antipsychotic drugs for residents of …

You must be logged-in to view this content.

Schizophrenia: Fast Facts

You must be logged-in to view this content.

APA Releases New Evidence-based Practice Guideline for Patients with Schizophrenia

Patients with schizophrenia should have documented, comprehensive, and person-centric treatment plans that include evidence-based nonpharmacologic and pharmacological treatments, according to …

You must be logged-in to view this content.

Substance Abuse, Mental Illness The Largest Predictors Of Frequent ED Use

The Affordable Care Act (ACA) OF 2010 was the largest expansion of health services in the United States in more …

You must be logged-in to view this content.

Absence of Major Depression & Substance Use Disorder More Likely After Recovery From Eating Disorder

You must be logged-in to view this content.

Marijuana Fact Sheet

You must be logged-in to view this content.

Follow Up Q&A With Dr. Rowland – The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

Follow Up Q&A With Dr. Murrough – The Role Of Glutamate In Mood Disorders & Schizophrenia

During this question and answer session, Dr. James Murrough responds to unanswered questions from the PsychU webinar, “The Role of …

You must be logged-in to view this content.

Implementing Measurement-Based Care—From Idea To Action

You must be logged-in to view this content.

Long-Acting Injectable Antipsychotics & How To Give An Intramuscular Injection

You must be logged-in to view this content.

Use Of Digital Health Activity Trackers Linked To Better Medication Adherence

People who use digital health activity trackers tend to be more adherent in taking medications prescribed for chronic health conditions. …

You must be logged-in to view this content.

Telepsychiatry Improves Access To Mental Health Care In Rural Areas

You must be logged-in to view this content.

American Foundation For Suicide Prevention Project 2025

You must be logged-in to view this content.

Cognitive Function & Neuroprotection In Schizophrenia

Schizophrenia has a worldwide prevalence of approximately 1%.1 Individuals living with the disease often experience neurocognitive deficits, as well as …

You must be logged-in to view this content.

Recovery After Initial Schizophrenic Episode – Early Treatment Program (RAISE-ETP)

You must be logged-in to view this content.

The Neurobiology Of Endocannabinoids

You must be logged-in to view this content.

Revisiting Cognitive Deficits In Bipolar Disorder

Neurocognitive deficits are commonly experienced by individuals living with bipolar disorder. Bipolar disorder is known to affect attention, processing speed, …

You must be logged-in to view this content.

The Neurobiology Of Opioids

You must be logged-in to view this content.

Giving Mental Illness A Voice: Patient Perspectives On Self-Disclosure & Stigma

Individuals living with mental illness often struggle with disclosing their mental health condition to others like friends, family, and employers, …

You must be logged-in to view this content.

State Of The Science 2019: REMS & Other Hot Topics In Bipolar Disorder Treatment

You must be logged-in to view this content.

State Of The Science 2019: Where Are We With Depression Care In The United States?

You must be logged-in to view this content.

Benefits & Challenges Of Smartphone Use In Mental Health

Pew Research Center statistics indicate that 95% of Americans now own some type of cellphone, and that 77% are smartphones.1 …

You must be logged-in to view this content.

After A Natural Disaster Or Tragedy: Behavioral Health Response Immediately Following A Mass Shooting (Part 8 Of 9)

In this interview, Deborah Blalock describes the behavioral health services immediately provided following the mass shooting which occurred on June …

You must be logged-in to view this content.

After A Natural Disaster Or Tragedy: Long-Term Behavioral Health Services In Response To A Mass Shooting (Part 9 Of 9)

In this interview, Deborah Blalock describes the long-term behavioral health services being provided in her community, to the congregation and …

You must be logged-in to view this content.

The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

Webinar Summary – The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

Webinar Summary – Gender Differences In Depression

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, …

You must be logged-in to view this content.

Webinar Summary – Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members …

You must be logged-in to view this content.

FDA Authorizes 23andMe Direct-To-Consumer Pharmacogenetic Reports

You must be logged-in to view this content.

The Use Of Psychopharmacology In Treatment For Depression In Pregnant & Nursing Women

In this interview, Jennifer Payne, MD, discusses common misconceptions surrounding the use of psychotropic medications to treat major depression or …

You must be logged-in to view this content.

Evolving Pharmacology Of Depression: Beyond The Monoamine Hypothesis

According to the World Health Organization, major depressive disorder (MDD) currently impacts 300 million individuals worldwide and is the leading …

You must be logged-in to view this content.

Webinar Summary – Evolving Psychopharmacology Of Depression: Beyond The Monoamine Hypothesis

You must be logged-in to view this content.

Neuromodulation Techniques: State Of The Science

Clinicians managing patients with behavioral health issues are presented with various diagnostic and treatment challenges, spanning the areas of neurobiology, …

You must be logged-in to view this content.

Webinar Summary – The Interplay Between Sleep & Bipolar Disorder

You must be logged-in to view this content.

What Did STAR*D Teach Us?: An Interview With Madhukar Trivedi, MD

In this interview, PsychU Major Depressive Disorder Section Editor, Professor of Psychiatry at UT Southwestern Medical Center and Director of …

You must be logged-in to view this content.

Where Are We Now? Recent Findings Push Research Beyond Initial Results From The CATIE Study

You must be logged-in to view this content.

Antidepressant Utilization In Bipolar Disorder: What Is The Evidence?

Depressive episodes are a major feature across the course of bipolar disorder and may frequently cause functional impairment.1 Antidepressants are often …

You must be logged-in to view this content.

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, & Therapy

You must be logged-in to view this content.

Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE): Summary Results From Phase I

In this presentation, Julleah Johnson, PhD, Senior Medical Science Liaison, summarized a study published by The New England Journal of …

You must be logged-in to view this content.

Treating The Synapse In Major Psychiatric Disorders: The Role of Postsynaptic Density Network In Dopamine-Glutamate Interplay & Psychopharmacologic Drugs Molecular Actions

You must be logged-in to view this content.

Early Intervention In Schizophrenia: Targeting Metabolic Dysfunction

Increasingly, schizophrenia is considered a medical psychiatric disease. There is evidence that metabolic changes occur within the first episode of …

You must be logged-in to view this content.

Webinar Summary – Pharmacogenomics & Personalized Medicine: Where Are We Now & Where Are We Going?

You must be logged-in to view this content.

Reduced Insulin-Receptor Mediated Modulation Of Striatal Dopamine Release By Basal Insulin As A Possible Contributing Factor To Hyperdomaminergia In Schizophrenia

You must be logged-in to view this content.

Clinical Application Of Psychopharmacology Of Schizophrenia – John Miller, MD

This interview with John Miller, MD is part 3 of the 3-part module series on Schizophrenia, from the Psychopharmacology Collection.

You must be logged-in to view this content.

No Supportive Evidence For The Use Of Multiple Long-Acting Antipsychotic Therapies In Patients With Schizophrenia

Does anyone use multiple LAI medications on one patient?

Although over a third of patients with schizophrenia in the United States …

You must be logged-in to view this content.

The Sequenced Treatment Alternatives To Relieve Depression: The STAR*D Study & Its Implications

You must be logged-in to view this content.

Clinical Application Of Psychopharmacology Of Bipolar Disorder – William Gilmer, MD

This interview with William Gilmer, MD, is part 3 of the 3-part module series on Bipolar Disorder from the Psychopharmacology …

You must be logged-in to view this content.

Dopamine Theory & Treatment Considerations In Schizophrenia

This video is part 1 in a series focusing on the psychopharmacology of schizophrenia. This video provides an overview of …

You must be logged-in to view this content.

Pathophysiology & Evolving Theories In Schizophrenia

This presentation is part 2 in a series focusing on the psychopharmacology of schizophrenia. This presentation reviews regions of the …

You must be logged-in to view this content.

Theories Of Bipolar Disorder Pathophysiology

This video is part 2 of a series on Bipolar Disorder, from the Psychopharmacology Collection. This video briefly reviews some …

You must be logged-in to view this content.

Webinar Summary – Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

This summary was developed utilizing the full recorded presentation of this virtual forum, which is available on PsychU for all …

You must be logged-in to view this content.

Advanced Receptor Psychopharmacology

This video is part 3 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This …

You must be logged-in to view this content.

Neurotransmitter Functioning In Major Depressive Disorder

This video is part 1 of a series on Major Depressive Disorder (MDD), from the Psychopharmacology Collection. This video introduces …

You must be logged-in to view this content.

Advanced Neurotransmitters & Neuroglia

This video is part 2 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This …

You must be logged-in to view this content.

Clinical Application Of Psychopharmacology Of Major Depressive Disorder – Chris Bojrab, MD

This interview with Chris Bojrab, MD, is part 3 of the 3-part module series on Major Depressive Disorder (MDD), from …

You must be logged-in to view this content.

Potential Role Of Neurotransmitters & Treatment Considerations In Bipolar Disorder

This video is part 1 of a series on Bipolar Disorder, from the Psychopharmacology Collection. This video briefly reviews the proposed …

You must be logged-in to view this content.

Pharmacologic Treatments In Major Depressive Disorder

This video is part 2 of a series on Major Depressive Disorder (MDD), from the Psychopharmacology Collection. This video provides …

You must be logged-in to view this content.

Follow Up Q&A – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

During this question and answer session, Henry A. Nasrallah, MD and Roger Sommi, PharmD, BCPP, FCCP respond to unanswered questions …

You must be logged-in to view this content.

Webinar Summary – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members …

You must be logged-in to view this content.

Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

While treating to remission is the goal in schizophrenia, it remains a target not achieved for many patients. In this …

You must be logged-in to view this content.

Antidepressant Drug-Induced Sexual Dysfunction

You must be logged-in to view this content.

Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry (Inflammation Series Part 1)

During this webinar, Dr. Roger S. McIntyre, Professor of Psychiatry and Pharmacology (University of Toronto), Head of the Mood Disorders …

You must be logged-in to view this content.

An Overview Of Treatment Options & Cost For Schizophrenia

During this recorded presentation, Aneta Fornal, PharmD, provided a brief overview of the treatment options and cost for schizophrenia. Key …

You must be logged-in to view this content.

Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

While past decades saw a boom in the development of innovative new treatments in the field of psychiatry, the pace …

You must be logged-in to view this content.

Basics In Psychopharmacology

This video is part 1 of the 3-part series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. …

You must be logged-in to view this content.

Application Of Pharmacology Knowledge To Clinical Practice

You must be logged-in to view this content.

Serotonin 1A & Serotonin 4 Receptors: Essential Mediators Of The Neurogenic & Behavioral Actions Of Antidepressants

You must be logged-in to view this content.

Antidepressant Drug Development: Focus On Triple Monoamine Reuptake Inhibition

You must be logged-in to view this content.

Identifying Predictors, Moderators, & Mediators Of Antidepressant Response In Major Depressive Disorder: Neuroimaging Approaches

You must be logged-in to view this content.

Major Depressive Disorder: Understanding The Significance Of Residual Symptoms & Balancing Efficacy With Tolerability

You must be logged-in to view this content.

Suboptimal Response In Psychotic & Mood Disorders: Causes, Consequences, & Management Strategies

Suboptimal response is a common challenge and can lead to negative consequences for patients diagnosed with serious mental illness. In …

You must be logged-in to view this content.

The Role Of NMDA Receptors In The Pathophysiology & Treatment Of Mood Disorders

You must be logged-in to view this content.

The Evolving Psychopharmacology Of Major Depressive Disorder

During this recorded presentation, David Scheiderer, MD, provided a brief overview of the psychopharmacology of major depressive disorder. Key points …

You must be logged-in to view this content.

Perspectives In Schizophrenia: Proposed Disease Pathophysiology & Potential Treatment Implications

During this recorded presentation, Robert E. Litman, MD, provided a brief overview of schizophrenia, the proposed disease pathophysiology, and implications …

You must be logged-in to view this content.

The Importance Of Norepinephrine In Depression

You must be logged-in to view this content.

Webinar Summary – Understanding The Role Of Neurotransmitters In The Treatment Of Depression

You must be logged-in to view this content.

Understanding The Role Of Neurotransmitters In The Treatment Of Depression

Major depressive disorder (MDD) is common, affecting an estimated 16 million US adults each year. However, less than 40% of …

You must be logged-in to view this content.

What Is The Relationship Between Major Depressive Disorder & Cognitive Dysfunction?

You must be logged-in to view this content.

Recognizing & Responding To Inadequately Treated Major Depressive Disorder (MDD): A Nursing Perspective

An estimated 1 in 10 US adults report depression, with major depressive disorder (MDD) as common as diabetes or coronary …

You must be logged-in to view this content.

The Neurobiology Of Relapse In Schizophrenia

You must be logged-in to view this content.

Dopamine Supersensitivity Psychosis (DSP): Is It A Factor in Treatment-Resistant Schizophrenia?

You must be logged-in to view this content.

Webinar Summary – The Evolving Psychopharmacology Of Major Depressive Disorder: Narrowing The Treatment Gap

You must be logged-in to view this content.

The Evolving Psychopharmacology Of Major Depressive Disorder: Narrowing The Treatment Gap

Depression is a widespread condition estimated to affect millions of adults in the United States alone. Despite the significant burden …

You must be logged-in to view this content.

Management Of Major Depressive Disorder (MDD): Breaking Through The Barriers

An estimated 1 in 10 US adults report depression, with major depressive disorder (MDD) as common as diabetes or coronary …

You must be logged-in to view this content.

“Braindoping” – Cosmetic Neurology Is Gaining Steam

You must be logged-in to view this content.

An Innovative Method Of Teaching Psychopharmacology To Psychiatry Residents

You must be logged-in to view this content.

Addex & NIAAA Form Collaboration To Evaluate Alcohol Use Disorder Drug

You must be logged-in to view this content.

The Nature Of Relapse In Schizophrenia

You must be logged-in to view this content.